Strumento inattivo

Altre lingue Pacgen Life Science Corp Toronto S.E.

Azioni

PBS

CA69374M1041

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Pacgen Life Science : Successfully Completes its Plan of Arrangement	30/09/20
Pacgen Life Science : IIROC Trading Halt - PBS	30/09/20
General Biologicals Corporation completed the acquisition of additional 77% stake in Pacgen Life Science Corporation.	30/09/20
Pacgen Life Science : Announces Shareholder Approval of Acquisition by General Biologicals Corporation	16/09/20
Pacgen Life Science Corporation Reports Earnings Results for the First Quarter Ended June 30, 2020	31/08/20
Pacgen Life Science Corporation Reports Earnings Results for the Full Year Ended March 31, 2020	29/07/20
Pacgen Life Science : Announces Proposed Acquisition by General Biologicals Corporation	07/07/20
General Biologicals Corporation entered into a letter of intent to acquire additional 77% stake in Pacgen Life Science Corporation for CAD 1.4 million.	07/07/20
Pacgen Life Science Corporation Reports Earnings Results for the Third Quarter Ended December 31, 2019	25/02/20
Pacgen Life Science Corporation Reports Earnings Results for the Second Quarter Ended September 30, 2019	29/11/19
Pacgen Life Science Corporation Reports Earnings Results for the First Quarter Ended June 30, 2019	29/08/19
Pacgen Life Science Corporation Reports Earnings Results for the Full Year Ended March 31, 2019	29/07/19
Pacgen Life Science Corporation Reports Earnings Results for the Third Quarter Ended December 31, 2018	02/03/19
Pacgen Life Science Corporation Announces Management Changes	28/03/18
Pacgen Life Science Corporation Appoints Rakesh Arya as Board of Directors	11/01/18
Pacgen Life Science Corporation announced that it has received CAD 0.74 million in funding	11/01/18
Pacgen Life Science Corporation Gains Exclusive Global Commercial Rights to DermaMed, DermaSoleil and Deserving Health	12/05/17
Pacgen Life Science Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2015	29/02/16
Pacgen Life Science Corporation announced that it has received CAD 0.32 million in funding from Southern Gold Resources Ltd and other investors.	03/02/16
Pacgen Life Sciences Corporation Announces Christina Yip to Board of Directors	19/01/16

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Pacgen Life Science Corp Toronto S.E.

Azioni

PBS

CA69374M1041

Altre lingue

Filtri